{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:51:09Z","timestamp":1777679469436,"version":"3.51.4"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Wilson\u2019s disease (WD) is a hereditary disorder that impairs copper metabolism. Both WD and its treatment with penicillamine are associated with renal impairment. We report a case of penicillamine-induced podocytopathy with pathological findings of early-stage focal segmental glomerulosclerosis (FSGS), which demonstrated rapid reversibility upon drug withdrawal alone. A 36-year-old female of East Asian origin with a 12-year history of WD presented with nephrotic syndrome after 21 months of penicillamine therapy. Her 24-h proteinuria was 6.58 g. Her renal biopsy revealed a podocytopathy with early-stage FSGS lesions. Following discontinuation of penicillamine, the proteinuria decreased to 0.04 g\/24 h and the nephrotic syndrome reached complete remission in 16 days without corticosteroid therapy. Remission persisted at the 1-year follow-up. This case illustrates that penicillamine can be a cause of reversible nephrotic syndrome secondary to podocytopathy with FSGS lesions and emphasizes the need for early biopsy in unusual proteinuria, with discontinuation of drugs as the main intervention. The clinician should have a high index of suspicion for drug toxicity in patients with WD and nephrotic syndrome, especially if the kidney injury is time-related to penicillamine therapy.<\/jats:p>","DOI":"10.3389\/fmed.2026.1802840","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:12:57Z","timestamp":1774843977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: A case of focal segmental glomerulosclerosis in Wilson\u2019s disease induced by penicillamine"],"prefix":"10.3389","volume":"13","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, Zibo Central Hospital, Zibo","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Zibo Central Hospital, Zibo","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Zibo Central Hospital, Zibo","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Zibo Central Hospital, Zibo","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMra1903585","article-title":"Current and emerging issues in Wilson\u2019s disease.","volume":"389","author":"Roberts","year":"2023","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12519-008-0019-5","article-title":"Analysis of renal impairment in children with Wilson\u2019s disease.","volume":"4","author":"Zhuang","year":"2008","journal-title":"World J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00223-019-00588-z","article-title":"Renal tubular function, bone health and body composition in Wilson\u2019s disease: a cross-sectional study from India.","volume":"105","author":"Kapoor","year":"2019","journal-title":"Calcif Tissue Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"sfae058","DOI":"10.1093\/ckj\/sfae058","article-title":"Kidney involvement in Wilson\u2019s disease: a review of the literature.","volume":"17","author":"Dang","year":"2024","journal-title":"Clin Kidney J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejim.2006.03.001","article-title":"Penicillamine and nephrotic syndrome.","volume":"17","author":"Habib","year":"2006","journal-title":"Eur J Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document.","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4103\/ijn.IJN_227_20","article-title":"IgA nephropathy with Wilson\u2019s disease: a case report and literature review.","volume":"31","author":"Bhandari","year":"2021","journal-title":"Indian J Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12876-021-01954-8","article-title":"Immunoglobulin a nephropathy as the first clinical presentation of Wilson disease: a case report and literature review.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e929","DOI":"10.7759\/cureus.929","article-title":"Immunoglobulin M nephropathy in a patient with Wilson\u2019s disease.","volume":"8","author":"Ul Abideen","year":"2016","journal-title":"Cureus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.medcli.2024.02.004","article-title":"Characterization of renal damage in Wilson\u2019s disease-detailed analysis of 20 Chinese cases.","volume":"163","author":"Jin","year":"2024","journal-title":"Med Clin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s40261-022-01117-x","article-title":"Adverse events with D-penicillamine therapy in hepatic Wilson\u2019s disease: a single-center retrospective audit.","volume":"42","author":"Kumar","year":"2022","journal-title":"Clin Drug Investig."},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"B13","first-page":"426","article-title":"[Focal segmental glomerulosclerosis presenting nephrotic syndrome and acute renal failure in a patient with rheumatoid arthritis].","volume":"39","author":"Sugiyama","year":"1997","journal-title":"Nihon Jinzo Gakkai Shi."},{"key":"B14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5414\/cn111402","article-title":"Kidney complications of Wilson disease and its treatments: a case report and literature review.","volume":"102","author":"Salman","year":"2024","journal-title":"Clin Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jmd2.12317","article-title":"Autoantibodies in Wilson disease: impact on clinical course.","volume":"63","author":"Antczak-Kowalska","year":"2022","journal-title":"JIMD Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.akdh.2024.03.009","article-title":"Focal segmental glomerulosclerosis.","volume":"31","author":"Suresh","year":"2024","journal-title":"Adv Kidney Dis Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2013.05.027","article-title":"D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms.","volume":"337","author":"Wadhwa","year":"2013","journal-title":"Cancer Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/life13061264","article-title":"Drug-Induced podocytopathies: report of four cases and review of the literature.","volume":"13","author":"Athanasopoulou","year":"2023","journal-title":"Life."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1802840\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:13:20Z","timestamp":1774844000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1802840\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":18,"alternative-id":["10.3389\/fmed.2026.1802840"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1802840","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1802840"}}